AP3344A - New dihydro-oxazolobenzodiazepinone compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

New dihydro-oxazolobenzodiazepinone compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
AP3344A
AP3344A AP2012006149A AP2012006149A AP3344A AP 3344 A AP3344 A AP 3344A AP 2012006149 A AP2012006149 A AP 2012006149A AP 2012006149 A AP2012006149 A AP 2012006149A AP 3344 A AP3344 A AP 3344A
Authority
AP
ARIPO
Prior art keywords
oxazolobenzodiazepinone
compounds
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
AP2012006149A
Other languages
English (en)
Other versions
AP2012006149A0 (en
Inventor
Michael Spedding
Ferenc Antoni
Laszlo Harsing
Original Assignee
Servier Lab
Egis Gyogyszergyar Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Egis Gyogyszergyar Nyrt filed Critical Servier Lab
Publication of AP2012006149A0 publication Critical patent/AP2012006149A0/xx
Application granted granted Critical
Publication of AP3344A publication Critical patent/AP3344A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AP2012006149A 2011-03-08 2012-03-06 New dihydro-oxazolobenzodiazepinone compounds, a process for their preparation and pharmaceutical compositions containing them AP3344A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1100682A FR2972454B1 (fr) 2011-03-08 2011-03-08 Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
AP2012006149A0 AP2012006149A0 (en) 2012-04-30
AP3344A true AP3344A (en) 2015-07-31

Family

ID=44004482

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2012006149A AP3344A (en) 2011-03-08 2012-03-06 New dihydro-oxazolobenzodiazepinone compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (44)

Country Link
US (1) US8778932B2 (ar)
EP (1) EP2497774B1 (ar)
JP (1) JP5475816B2 (ar)
KR (1) KR101477991B1 (ar)
CN (1) CN102675341B (ar)
AP (1) AP3344A (ar)
AR (1) AR085691A1 (ar)
AU (1) AU2012201031B2 (ar)
BR (1) BR102012005137A2 (ar)
CA (1) CA2771189C (ar)
CL (1) CL2012000496A1 (ar)
CR (1) CR20120109A (ar)
CU (1) CU24134B1 (ar)
CY (1) CY1114729T1 (ar)
DK (1) DK2497774T3 (ar)
EA (1) EA021125B1 (ar)
EC (1) ECSP12011711A (ar)
ES (1) ES2442293T3 (ar)
FR (1) FR2972454B1 (ar)
GE (1) GEP20146017B (ar)
GT (1) GT201200066A (ar)
HN (1) HN2012000485A (ar)
HR (1) HRP20140050T1 (ar)
IL (1) IL218215A (ar)
JO (1) JO2948B1 (ar)
MA (1) MA33641B1 (ar)
MX (1) MX2012002788A (ar)
MY (1) MY162537A (ar)
NI (1) NI201200039A (ar)
NZ (1) NZ598625A (ar)
PE (1) PE20121682A1 (ar)
PH (1) PH12012000035A1 (ar)
PL (1) PL2497774T3 (ar)
PT (1) PT2497774E (ar)
RS (1) RS53032B (ar)
RU (1) RU2572556C2 (ar)
SA (2) SA112330331B1 (ar)
SG (1) SG184633A1 (ar)
SI (1) SI2497774T1 (ar)
TW (1) TWI428342B (ar)
UA (1) UA112153C2 (ar)
UY (1) UY33927A (ar)
WO (1) WO2012120206A1 (ar)
ZA (1) ZA201201681B (ar)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230684B1 (hu) 2014-01-21 2017-08-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Új dihidro-oxazino-benzodiazepin vegyületek és eljárás ezek elõállítására, illetve az ezeket tartalmazó gyógyászati készítmények
DE102016005291B4 (de) 2016-04-29 2024-01-11 Ksg Austria Gmbh Verfahren zur Herstellung eines elektronischen Gerätes in der Form eines Spritzgußteils mit eingelegter Leiterplatte

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007708A1 (en) * 1997-08-12 1999-02-18 EGIS Gyógyszergyár Rt. 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors
WO2001004122A2 (en) * 1999-07-07 2001-01-18 EGIS Gyógyszergyár Rt. New 2,3-benzodiazepine derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0101223B1 (en) 1982-08-06 1987-04-01 Ube Industries, Ltd. process for producing phenylacetones
US5891871A (en) * 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
GB9900222D0 (en) * 1999-01-06 1999-02-24 Merck Sharp & Dohme Therapeutic compounds
JP2009513644A (ja) * 2005-10-26 2009-04-02 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 治療組成物および方法
HU230760B1 (hu) * 2005-12-30 2018-03-28 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Dihidro-2,3-benzodiazepin-származékok optikai izomerjei, eljárás ezek sztereoszelektív szintézisére, alkalmazásuk, az ezeket tartalmazó gyógyszerkészítmények és az eljárás közbenső termékei
EP2298296A1 (en) * 2009-08-25 2011-03-23 CNRS Centre National De La Recherche Scientifique Composition and method for treating cognitive impairments in down syndrome subjects

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007708A1 (en) * 1997-08-12 1999-02-18 EGIS Gyógyszergyár Rt. 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors
WO2001004122A2 (en) * 1999-07-07 2001-01-18 EGIS Gyógyszergyár Rt. New 2,3-benzodiazepine derivatives

Also Published As

Publication number Publication date
TW201309708A (zh) 2013-03-01
DK2497774T3 (da) 2014-01-13
CL2012000496A1 (es) 2014-07-18
JO2948B1 (ar) 2016-03-15
CA2771189C (fr) 2014-06-10
SG184633A1 (en) 2012-10-30
EP2497774B1 (fr) 2013-10-16
HRP20140050T1 (hr) 2014-02-14
CY1114729T1 (el) 2016-10-05
JP5475816B2 (ja) 2014-04-16
GEP20146017B (en) 2014-01-27
PL2497774T3 (pl) 2014-03-31
UA112153C2 (uk) 2016-08-10
FR2972454B1 (fr) 2013-03-01
AP2012006149A0 (en) 2012-04-30
EA021125B1 (ru) 2015-04-30
FR2972454A1 (fr) 2012-09-14
KR20120102550A (ko) 2012-09-18
HK1176355A1 (en) 2013-07-26
UY33927A (es) 2012-09-28
CU20120041A7 (es) 2013-10-29
KR101477991B1 (ko) 2014-12-31
GT201200066A (es) 2013-10-10
WO2012120206A1 (fr) 2012-09-13
ECSP12011711A (es) 2012-07-31
JP2012188422A (ja) 2012-10-04
RU2013144824A (ru) 2015-04-20
MX2012002788A (es) 2012-09-07
US8778932B2 (en) 2014-07-15
CR20120109A (es) 2012-10-05
NI201200039A (es) 2012-11-09
CU24134B1 (es) 2015-11-27
RU2572556C2 (ru) 2016-01-20
SI2497774T1 (sl) 2014-02-28
AU2012201031A1 (en) 2012-09-27
ZA201201681B (en) 2012-11-28
PH12012000035A1 (en) 2013-09-09
AU2012201031B2 (en) 2015-05-07
TWI428342B (zh) 2014-03-01
PE20121682A1 (es) 2012-12-08
ES2442293T3 (es) 2014-02-11
IL218215A0 (en) 2012-07-31
HN2012000485A (es) 2015-05-11
RS53032B (sr) 2014-04-30
BR102012005137A2 (pt) 2015-06-16
SA112330331B1 (ar) 2014-12-01
US20120232065A1 (en) 2012-09-13
PT2497774E (pt) 2013-11-26
CA2771189A1 (fr) 2012-09-08
EP2497774A1 (fr) 2012-09-12
MY162537A (en) 2017-06-15
CN102675341B (zh) 2015-02-25
CN102675341A (zh) 2012-09-19
MA33641B1 (ar) 2012-10-01
AR085691A1 (es) 2013-10-23
SA112330231B1 (ar) 2014-12-01
NZ598625A (en) 2013-06-28
EA201200267A1 (ru) 2012-10-30
IL218215A (en) 2016-04-21

Similar Documents

Publication Publication Date Title
AP2014007774A0 (en) New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
IL233663A0 (en) New indolizine compounds, a process for their preparation and pharmaceutical preparations containing them
IL230218A (en) Converted atherothecyclic compounds, their preparations and their pharmaceutical preparations
ZA201405323B (en) New pyrrole compounds ,a process for their preparation and pharmaceutical compositions containing them
AP3864A (en) Pharmaceutical composition
AP3050A (en) New Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions comprising them
ZA201405418B (en) New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
IL243742A0 (en) New indolizine compounds, a process for their preparation and pharmaceutical preparations containing them
SG11201400580VA (en) Pharmaceutical composition for inhalation
GB201118232D0 (en) Pharmaceutical composition
IL232577A (en) History of morpholinylbenzotriazine, their preparation and their pharmaceutical preparations
IL207183A0 (en) New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
IL223872A (en) Pyrazoloquinoline derivatives and intermediates, process for preparation, use and pharmaceutical preparations and preparations containing them
IL228821A0 (en) Pharmacy preparation
IL230219A0 (en) History of dihydropyrazole, their preparation and pharmaceutical preparations containing them
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION
AP3344A (en) New dihydro-oxazolobenzodiazepinone compounds, a process for their preparation and pharmaceutical compositions containing them
HUP1100532A2 (en) Substituted curcumin derivatives, process for their preparation, and pharmaceutical compositions containing them
AP2012006308A0 (en) New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them.
HUP1100444A2 (en) Pharmaceutical composition
IL206885A0 (en) New chromene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201106353B (en) Dihydrobenzoxathiazepine compounds,a process for their preparation and pharmaceutical compositions containing them
AP2010005304A0 (en) New 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them
HUP1100445A2 (en) Pharmaceutical composition